NEXT Dallas is a clinical research site located in Irving, Texas, United States 75039.
Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.
NEXT Dallas has participated in 24 clinical trials with 22 currently active.
Therapeutic areas: Solid Tumors, Advanced or Metastatic Solid Tumors, Advanced Malignancies.
Sponsors: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD., Takeda, PharmaMar.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Irving
Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NEXT Dallas has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NEXT Dallas has 24 clinical trials on record, with 22 currently active. Their work covers Solid Tumors, Advanced or Metastatic Solid Tumors, Advanced Malignancies.
NEXT Dallas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.